 Connection
Laurie Carr to Humans
This is a "connection" page, showing publications Laurie Carr has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.164 |
|
|
|
-
Li HY, Carr LL. Predictive Biomarkers of Response to Src Inhibitors in Lung Cancer. Getting to YES1. Am J Respir Crit Care Med. 2019 Oct 01; 200(7):802-804.
Score: 0.019
-
Carr LL, Jacobson S, Bowler RP. Response. Chest. 2018 09; 154(3):721.
Score: 0.017
-
Carr LL, Jacobson S, Lynch DA, Foreman MG, Flenaugh EL, Hersh CP, Sciurba FC, Wilson DO, Sieren JC, Mulhall P, Kim V, Kinsey CM, Bowler RP. Features of COPD as Predictors of Lung?Cancer. Chest. 2018 06; 153(6):1326-1335.
Score: 0.017
-
Carr LL, Kern JA, Deutsch GH. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Neuroendocrine Hyperplasia of Infancy. Clin Chest Med. 2016 09; 37(3):579-87.
Score: 0.015
-
Carr LL, Zelarney P, Meadows S, Kern JA, Long MB, Kern E. Development of a Cancer Care Summary Through the Electronic Health Record. J Oncol Pract. 2016 Feb; 12(2):e231-40.
Score: 0.014
-
Carr LL, Chung JH, Duarte Achcar R, Lesic Z, Rho JY, Yagihashi K, Tate RM, Swigris JJ, Kern JA. The clinical course of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Chest. 2015 Feb; 147(2):415-422.
Score: 0.013
-
Jett JR, Carr LL. Targeted therapy for non-small cell lung cancer. Am J Respir Crit Care Med. 2013 Oct 15; 188(8):907-12.
Score: 0.012
-
Jett JR, Carr LL. Systemic treatment of advanced lung carcinoid tumors: show me the data! Chest. 2013 Apr; 143(4):884-886.
Score: 0.012
-
Carr LL, Finigan JH, Kern JA. Evaluation and treatment of patients with non-small cell lung cancer. Med Clin North Am. 2011 Nov; 95(6):1041-54.
Score: 0.011
-
Carr LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG. Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation. Clin Cancer Res. 2010 Nov 01; 16(21):5260-8.
Score: 0.010
-
Carr LL, Gottschling DE. Does age influence loss of heterozygosity? Exp Gerontol. 2008 Mar; 43(3):123-9.
Score: 0.008
-
Dyer DS, Zelarney PT, Carr LL, Kern EO. Improvement in Follow-up Imaging With a Patient Tracking System and Computerized Registry for Lung Nodule Management. J Am Coll Radiol. 2021 07; 18(7):937-946.
Score: 0.005
-
Uthoff J, Stephens MJ, Newell JD, Hoffman EA, Larson J, Koehn N, De Stefano FA, Lusk CM, Wenzlaff AS, Watza D, Neslund-Dudas C, Carr LL, Lynch DA, Schwartz AG, Sieren JC. Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT. Med Phys. 2019 Jul; 46(7):3207-3216.
Score: 0.005
-
Patil T, Aisner DL, Noonan SA, Bunn PA, Purcell WT, Carr LL, Camidge DR, Doebele RC. Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status. Lung Cancer. 2016 06; 96:27-32.
Score: 0.004
-
Bauman JE, Eaton KD, Wallace SG, Carr LL, Lee SJ, Jones DV, Arias-Pulido H, Cerilli LA, Martins RG. A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer. BMC Cancer. 2012 Oct 03; 12:449.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|